



Thomas A. Hopf,1,2 Lucy J. Colwell,3 Robert Sheridan,4 Burkhard Rost,2 Chris Sander,4 and Debora S. Marks1,*
1Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
2Department of Informatics, Technische Universita¨t Mu¨nchen, 85748 Garching, Germany
3MRC Laboratory of Molecular Biology, Hills Road, CB2 0QH Cambridge, UK
4Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA
*Correspondence: evfold_membrane@cbio.mskcc.org
DOI 10.1016/j.cell.2012.04.012SUMMARY
We show that amino acid covariation in proteins, ex-
tracted from the evolutionary sequence record, can
be used to fold transmembrane proteins. We use
this technique to predict previously unknown 3D
structures for 11 transmembrane proteins (with up
to 14 helices) from their sequences alone. The predic-
tion method (EVfold_membrane) applies a maximum
entropy approach to infer evolutionary covariation in
pairs of sequence positions within a protein family
and then generates all-atommodels with the derived
pairwise distance constraints. We benchmark the
approach with blinded de novo computation of
known transmembrane protein structures from 23
families, demonstrating unprecedented accuracy of
the method for large transmembrane proteins. We
show how the method can predict oligomerization,
functional sites, and conformational changes in
transmembrane proteins. With the rapid rise in
large-scale sequencing, more accurate and more
comprehensive information on evolutionary con-
straints can be decoded from genetic variation,
greatly expanding the repertoire of transmembrane
proteins amenable to modeling by this method.INTRODUCTION
Membrane proteins allow cells to interact with the extracellular
environment and to communicate with other cells. More than
25% of all human proteins have integral membrane domains;
many of these are medically important, with nearly half of all
drug targets containing a membrane domain (Bakheet and Doig,
2009; Overington et al., 2006). Knowing the three-dimensional
(3D) structure of a membrane protein facilitates the characteriza-
tions its molecular mechanism and accelerates the development
of pharmacological agents targeting it (Katritch et al., 2012).
Despite great progress in determining structures by experimentalmethods (Chen et al., 2010; Cherezov et al., 2007; Choe et al.,
2011; Long et al., 2007; Miller and Long, 2012; Rasmussen
et al., 2011; Rasmussen et al., 2007), the 3D structures of most
transmembrane proteins remain unknown, and comparative
modeling maximally covers 10% of all human transmembrane
proteins. Efficient and accurate computational approaches that
predict 3D structures of membrane proteins would be a valuable
tool to complement existing experimental approaches.
Well-established methods of structure prediction, such as
energy minimization and database fragment searches, have
previously addressed the problem of prediction of transmem-
brane protein structures. However, these calculations were
limited in both protein size (%7 transmembrane helices) and
accuracy, despite added information on helix-helix contact
predictions from experimentally nonhomologous structures
and a few known experimentally determined contacts (Barth
et al., 2009; Yarov-Yarovoy et al., 2006).
It is possible that constraints on the function and structure of
proteins are reflected in conserved interactions between pairs,
or groups, of amino acids. If so, then evolutionary correlations
maybe observed between specific sequence positions. Previous
work has attempted to use correlations between residues,
among other methods, to predict structural proximity and func-
tional features (Cronet et al., 1993; Fatakia et al., 2009; Fuchs
et al., 2007; Go¨bel et al., 1994; Horn et al., 1998; Nemoto et al.,
2004). Themost accurate of these strategies useglobal statistical
methods, such as maximum entropy (Marks et al., 2011; Morcos
et al., 2011), Bayesian networks (Burger and van Nimwegen,
2010), or covariance estimation (Jones et al., 2012;Meinshausen
andBuhlmann, 2006). However, only recently it was reported that
a maximum entropy analysis of residue correlations in sequence
families could provide sufficient information about proximity of
residues in 3D to compute correct folds of protein structures in
15 example cases, using EVfold (Marks et al., 2011).
Here, we report the development of an algorithm, EVfold_mem-
brane, which enables de novo prediction of 3D structures of
unknown a-helical transmembrane proteins from evolutionary
constraints, using neither fragments, threading, nor homologous
3D structures. We predict the structures of 11 transmembrane
proteins of unknown structure, including eight pharmacological
targets (Figure 1, Table 1, and Figure S1 available online). To verifyCell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc. 1607
Figure 1. De Novo Predicted 3D Models of Membrane Proteins with No Known Structure
Cartoon shows evolutionary couplings as calculated by EVfold; membrane placed as distance constraints on extended polypeptide before folding. Top-ranked
models of a representative set of six transmembrane proteins from diverse families, which have no members with known 3D structures. Models are cartoon
representation with rainbow coloring blue N terminal to red C terminal, seen from the side (left) and noncytoplasmic side (right). Naming conventions, 3D
coordinates, and input files in are shown in Tables 1 and S1 and Data S1–S5.that our predicted structures are plausible, we systematically test
our ability to predict, in blinded fashion, the structures of a diverse
set of 25 transmembrane proteins with known 3D structures
(Table 1) and find an unprecedented level of agreement with the
cognate crystal structures (TM scores > 0.5 for 22 out of 25 of the
benchmarkedproteins).Wefind that functionally important regions
of each protein tend to be more accurately predicted than the
protein as a whole and that residues that are subject to multiple
pair constraints tend to be in substrate binding pockets, oligomer-
ization interfaces, and/or involved in conformational changes.
RESULTS
Global Statistical Approach for Protein Structures
from Sequences
Our hypothesis is that evolution conserves interactions between
residues that are important to maintaining structure and function1608 Cell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc.by constraining the sets of mutations that are accepted at
interacting sites. To find these constraint couplings for each
membrane protein, we build a multiple sequence alignment (Re-
mmert et al., 2012) with sufficiently diverse sequences to detect
evolutionary covariation and minimize statistical noise. To maxi-
mize the power of detection, we developed amethod to optimize
the trade-off between the number of sequences aligned (i.e.,
depth) and alignment specificity, a proxy for functional similarity
to the query sequence, which is quantified by the sequence
range (i.e., breadth) covered by the alignment (Figures 2A, S2,
and Experimental Procedures). For example, for bovine Ant1,
which catalyzes the exchange of cytoplasmic ADP with mito-
chondrial ATP, we use a stringency value (E) of 10-40, ensuring
that 70% of its residues in the sequence are covered by the
alignment. In general, for a protein of length L, we require at least
3L sequences and coverage of at least 0.73 L of the residues in
the sequence of interest.
Table 1. Predicted Proteins of Known and Unknown Experimental Structure
Uniprot Name Length TMHa E-valb
Model
Length #Seqc Top #d TMe Ca-rmsdf Best #d TMe Ca-rmsdf PDBg
Known Structure
ADIC_SALTY 445 12 E-20 394 24284 240_15 0.67 4.2 (300) 240_15 0.67 4.2 (300) 3ncyA
ADRB2_HUMAN 413 7 E-20 296 35593 160_5 0.67 3.3 (201) 160_5 0.67 3.3 (201) 2rh1A
ANT1_BOVIN 298 6 E-40 285 9828 200_20 0.48 3.8 (136) 270_17 0.51 4.0 (152) 1okcA
AMTB_ECOLI 428 10 E-5 396 4407 270_17 0.67 3.9 (262) 280_5 0.67 3.6 (260) 1xqfA
AQP4_HUMAN 323 6 E-10 215 6469 80_19 0.50 2.9 (100) 100_14 0.51 3.4 (110) 3gd8A
BTUC_ECOLI 326 10 E-10 299 12926 250_19 0.67 3.2 (209) 250_19 0.67 3.2 (209) 1l7vA
C3NQD8_VIBCJ 461 12 E-20 431 13864 250_11 0.62 4.6 (306) 290_8 0.63 4.3 (305) 3mktA
C6E9S6_ECOBD 485 14 E-10 412 63730 180_9 0.63 4.2 (299) 180_9 0.63 4.2(299) 3rkoN
COX1_BOVIN 514 12 E-40 486 73822 150_6 0.66 4.5 (360) 150_11 0.66 4.4 (354) 1occA
COX3_BOVIN 261 7 E-3 182 10705 50_9 0.69 2.8 (151) 50_9 0.69 2.8 (151) 1occC
CYB_BOVIN 379 8 E-3 335 43891 120_4 0.58 4.1 (203) 100_9 0.64 3.7 (231) 1pp9B
FIEF_ECOLI 300 6 E-5 197 9722 200_10 0.59 2.8 (119) 40_7 0.63 2.8 (131) 3h90A
GLPG_ECOLI 276 6 E-5 169 5263 120_11 0.64 2.6 (126) 120_11 0.64 2.6 (126) 3b45A
GLPT_ECOLI 452 12 E-30 402 24912 330_12 0.67 3.8 (283) 330_13 0.67 4.0 (297) 1pw4A
METI_ECOLI 217 6 E-15 206 30400 120_17 0.46 3.5 (93) 120_6 0.48 3.4 (94) 3dhwA
MIP_BOVIN 263 6 E-10 212 6468 150_12 0.55 3.1 (116) 130_20 0.58 2.9 (124) 1ymgA
MSBA_SALTY 330 6 E-3 310 29034 100_12 0.57 3.3 (180) 110_12 0.61 3.5 (208) 3b60A
O67854_AQUAE 513 12 E-3 463 4500 280_4 0.55 5.1 (274) 170_20 0.58 4.8 (286) 2a65A
OPSD_BOVIN 348 7 E-20 274 35901 110_16 0.70 3.3 (214) 110_16 0.70 3.3 (214) 1hzxA
Q87TN7_VIBPA 485 8 E-10 407 4097 270_12 0.59 4.0 (242) 260_19 0.60 4.2 (258) 3pjzA
Q8EKT7_SHEON 516 12 E-10 447 12063 100_14 0.40 4.6 (160) 240_19 0.43 4.8(183) 2xutA
Q9K0A9_NEIMB 315 10 E-10 297 4244 270_9 0.44 3.6 (131) 120_9 0.49 3.9 (138) 3zuxA
SGLT_VIBPA 543 14 E-5 487 9563 310_11 0.49 4.6 (214) 340_10 0.53 4.8 (264) 2xq2A
TEHA_HAEIN 328 10 E-3 304 1861 70_15 0.51 4.1 (154) 210_17 0.56 4.0 (175) 3m71A
URAA_ECOLI 429 14 E-3 393 14992 250_12 0.50 4.8 (194) 250_5 0.50 4.5 (189) 3qe7A
Unknown Structure Structural Similarity to Zh Ca-rmsdf PDBg
ADR1_HUMAN 375 7 E-5 223 3410 150_14 bacteriorhodopsin 12 4.5 (204) 3haoA
NU1M_HUMAN 318 8 E-10 282 17558 210_18 mit. complex 1 subunit L 10 5.0 (170) 3rkoL
S22A4_HUMAN 551 12 E-30 373 21704 220_11 L-fucose permease FucP 10 6.0 (267) 3o7qA
ABCG2_HUMAN 655 7 E-10 274 5404 210_3
ELOV4_HUMAN 314 7 E-3 233 1436 190_6
SL9A1_HUMAN 815 13 E-10 367 6020 210_17 acriflavine res. prot. AcrB 4 4.7 (165) 2gifA
MSMO1_HUMAN 293 5 E-20 220 897 70_13
S13A1_HUMAN 595 15 E-20 543 1836 nonei
EAMA_ECOLI 299 10 E-5 276 31753 250_10
LIVH_ECOLI 308 8 E-3 282 23968 230_16 permease protein BtuC 6 4.1 (140) 1l7vA
GABR1_HUMAN 961 7 E-5 298 2871 190_19 b2 adrenergic receptor 6 6.0 (191) 3p0gA
aNumber of transmembrane helices.
bE value for HHblits sequence search.
cNumber of sequences in multiple sequence alignment.
dNumber of evolutionary constraints used and model number of blind top-ranked and best-generated model, respectively.
eTM score.
fCa, root-mean-square deviation in A˚ (number of residues).
gAccession code and chain of similar PDB structure that has negligible sequence similarity.
hDALI Z score.
iNo model looks plausible (large protein, few sequences).
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Figure 2. From Sequence Alignment to Folded Structures
(A) Building the alignment for the EC calculation for the specific query protein requires a trade-off between specificity and diversity. To investigate this blindly, we
scan a range of alignment depths using different expectation values and calculate the effective number of sequences returned (diversity) and the number of
residues in our query protein sequence that do not havemore than 30%gaps in the alignment column of the alignment (coverage). Dashed arrows point to chosen
stringency for folding. Contrast in the distribution of sequence space at different alignment depths in histograms of the range of number of sequences with the
0%–100% identity to query protein sequence (insets, middle).
(B) Schematic showing constraint conflict resolution between predicted coevolution and predicted secondary structure/membrane topology. In all cases we
follow the predicted membrane topology and discard coevolving residue pairs that conflict with this prediction. The predicted toy contact map (middle) shows
1610 Cell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc.
To discover residue interactions that are conserved by evolu-
tion, we developed an algorithm that extracts patterns of amino
acid coevolution from these sequence alignments (Lapedes
et al., 1997; Marks et al., 2011; Morcos et al., 2011). The algo-
rithm, which uses entropy maximization, transforms the set of
observed amino acid correlations in all pairs of sequence posi-
tions to a set of position couplings (residue couplings) that
best explains the observed data. This set of globally consistent
residue couplings is likely to be causative, i.e., likely to reflect
residue interactions constrained in evolution. Our statistical
approach is thus in a class of algorithms that address the classic
problem of deriving ‘‘causation from correlation.’’ Our ‘‘global’’
statistical approach is different from ‘‘local’’ approaches such
as mutual information (MI) and variants thereof (Fodor and Al-
drich, 2004; Livesay et al., 2012). The MI of pairs of columns in
a sequence alignment is local in that it quantifies covariation
for each pair independently of all other pairs, potentially leading
to inconsistencies. The simplest inconsistencies in local models
are transitive correlations, e.g., correlations between a noncon-
tact pair A-C in a triplet A-B-C that arise from transitive influence
in contact pairs A-B and B-C. Thus, pairs with high MI scores are
not necessarily constrained by a direct interaction effect, even if
they are correlated.
In contrast, our entropy maximization approach builds a prob-
ability model for the entire sequence, such that the scores for
each pair of residues are consistent with other pairs, thereby pre-
venting high scoring from transitive relationships in the data.
Starting with a simple covariance matrix between all pairs of
columns in the alignment, entropy maximization gives rise to
a formalism that is similar to the well-known inverse Ising model
of ferromagnetism (in which there are two states) except that, for
protein sequences, each site (i.e., sequence position) can be as-
signed to 1 of 21 discrete states (20 amino acids or a gap), as in
the Potts model in physics. The numerical parameters in the
entropy maximization method (analogous to the spin-spin inter-
actions in the Ising model Hamiltonian) can be computed effi-
ciently by inverting a covariance matrix. This algorithmic entropy
maximization solution is similar to partial correlation methods in
Gaussian graphical models for continuous distributions (Demp-
ster, 1972). In entropy maximization, after the covariance matrix
inversion, the residue pair scores, or evolutionary coupling
scores, are consistent with the correlation data between pairs
of positions and single column data, including conservation,
while making a minimum set of other assumptions. Although
constrained interactions can arise from diverse evolutionary
requirements, we find that many reflect interactions between
residues close in space and are thus highly productive as
distance constraints for protein folding (Marks et al., 2011).
The structure of transmembrane proteins is additionally con-
strained by the presence of the membrane. Hence, we can
blindly remove predicted coevolved pairs for which 3D proximityevolutionary constraints that conflict with the predicted membrane topology that
predicted membrane topology are not removed, irrespective of any knowledge a
(C) The top-ranked model from the set of each de novo predicted structure was c
and Sander, 1995). Three of the six predicted 3D TM protein structures with sign
See also Figure S2.is unlikely (Figures 2B and S3 and Experimental Procedures).
The resulting set of evolutionary constraints and the predicted
secondary structure are interpreted as distance constraints on
extended polypeptide chains (Data S1). Distance geometry
and out-of-the-box simulated annealing using the CNS software
(Bru¨nger et al., 1998) are used to fold the chain ab initio to
produce 500 3D all-atom coordinate models for each protein.
To assess the set of predicted structures for each protein, we
apply an automated membrane-specific ranking of the com-
puted models that combines the quality of secondary structure
formation, lipid accessibility of the residues, and a measure of
violation of the evolutionary constraints and cluster the struc-
tures, excluding predictions not represented in the larger clus-
ters (Experimental Procedures).
Prediction of Unknown 3D Structures of a-Helical
Transmembrane Proteins
A survey of targets in the DrugBank database (Knox et al., 2011)
for transmembrane proteins together with large families from
the CAMPS (Neumann et al., 2012) yielded 18 nonredundant
families with >1,000 sequences, with R5 predicted transmem-
brane helices, and without a known 3D structure for any family
member. We selected 11 of these targets for detailed analysis,
covering diverse sizes and functional types, with several of the
families having more than one drug target (Tables 1 and S1 and
Experimental Procedures). Coordinates for the remaining seven
families are available at http://evfold.org/transmembrane. These
proteins are implicated in many diseases, including diabetes,
obesity, Crohn’s disease, breast cancer, Leber hereditary optic
neuropathy, Alzheimer’s disease, and Parkinson’s disease
(Holland et al., 2011; Pei et al., 2011; Peltekova et al., 2004;
Yamauchi et al., 2003; Doyle et al., 1998; Natarajan et al., 2012;
Howell et al., 1991; Jaksch et al., 1996; Aldahmesh et al., 2011;
Zhang et al., 2001). We predicted 400–600 all-atom 3D models
for eachprotein (DataS2andExperimental Procedures). Thepre-
dicted structures of five of the proteins had similar folds to other
known3Dmembraneprotein structures (Figure 2C) despite negli-
gible sequence similarity, a recurring theme seen in structural
genomics and earlier work (Holm and Sander, 1993; Murzin,
1993). Predicted structures of three membrane proteins show
some structural similarities to those of other sequence-distant
members of the same PFAM clan. A search against all known
3D structures with our top-ranked model of the human OCTN1,
a 12 helical transporter sugar transporter, yields several signifi-
cant hits to structures in the major facilitator superfamily,
including FucP (PDB: 3o7q; Dang et al., 2010) and GlpT (PDB:
1pw4; Law et al., 2008) (Figures 1 and 2C and Tables 1 and S1).
FucP and GlpT sequences were not in our alignment and have
only 10% and 7% sequence identity to OCTN1, respectively,
below the level allowing inference of structural homology. Simi-
larly, the 8 transmembrane helical E. Coli LIVH, a high-affinityare removed (black stars). Evolutionary constraints that do not conflict with the
bout their distance in 3D space (constraint 1).
ompared to the entire PDB using the structural alignment program DALI (Holm
ificant structural similarities to known transmembrane protein folds are shown.
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leucine transporter, is structurally similar to the bacterial B12
uptake protein BtuC (PDB: 1l7v; Locher et al., 2002) despite
only 8% sequence identity between the proteins (Tables 1 and
S1). Third, the predicted structures of the GABA receptor 1,
a protein involved in synaptic inhibition and a pharmacological
target, are structurally similar to otherGPCRsdespite a negligible
sequence identity (10%) (Figures 1 andS1 and Table 1). Although
this result is not so surprising, the sequence diversity in GPCRs
is sufficiently high that de novo computation of the 3D structure
from evolutionary couplings may be of interest, in addition to
model building by remote homology (Katritch et al., 2012)
(Figures 1 and S1 and Table 1). In the predicted models of the
GABA receptor, a lack of well-ordered structure formed by the
extracellular loops and a lack of b sheet formation by the pre-
dicted b strands indicate potential model errors. Nevertheless,
high-scoring predicted residue pair interactions in the extracel-
lular region, specifically between loops 2/3 and 3/4, are located
close to the putative extracellular ligand-binding domain. Given
the moderate number of sequences in this GABA receptor
family, we expect the current accuracy to be limited, but the
models may serve as a useful starting point for further iteration
using hybrid approaches and different alignment depths.
The five top-ranked predicted adiponectin receptor 3D struc-
tures are surprisingly similar (4.5 A˚ Ca-rmsd over 204 residues)
to the bacteriorhodopsin crystal structure (PDB: 3hao), with
highly significant Dali (Holm and Sander, 1995) Z scores between
7 and 13, despite negligible sequence identity (8%) (Figures 1
and 2C and Data S2). Although adiponectin receptor is a 7
transmembrane protein, it was not previously thought to have
structural or functional similarity to G protein-coupled receptors
and is inverted with respect to the membrane (Yamauchi et al.,
2003). Assuming that our predictions are accurate, it remains
an open question whether the similarity of AdipoR1 to the
GPCR fold is an example of divergent evolution or the result of
convergent evolution to an exceptionally robust 7 helical fold.
We also find significant structural similarity of predicted
structures of the human MT-ND1 subunit to the recently solved
structure of one of the major membrane subunits of respiratory
complex I (E. coli, 3rko-C; NuoL subunit) (Efremov and Sazanov,
2011); again, the sequences of MT-ND1 and the NuoL subunit
are unrelated, with <8% identity. However, we do not find
high topological similarity to the coarse grained model of the
bacterial NuoL subunit (homologous to MT_ND1), which was
solved at low resolution without residue assignment (Efremov
et al., 2010), and the NuoL subunit is almost double the size of
our modeled protein. Nevertheless, our MT-ND1 structures
overlay optimally on precisely the regions of bacterial subunits
that are structurally duplicated within each protein (in NuoL,
TM helices 3–7 and 8–15), further supporting the idea that
this is a repeating structural evolutionary module (Efremov and
Sazanov, 2011). Because these mitochondrial subunits are
functionally related and spatially coincident throughout evolu-
tion, the structural relationship between them may plausibly
result from divergent evolution of the sequence. Taken together,
these examples of structural relationships between the pre-
dicted models and the structures of functionally related but
sequence-distant proteins provide support for the accuracy of
the de novo prediction.1612 Cell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc.Benchmark: Blinded Prediction of Transmembrane
Proteins of Known 3D Structure
To evaluate the performance of the prediction protocol, we
computed the 3D structures of a-helical membrane proteins
of known structure from the proteins’ sequences alone, i.e.,
ignoring all aspects of known 3D structures, including
sequence-similar fragments. We selected all a-helical mem-
brane proteins from all Pfam families that have >1,000
sequences, sufficient sequence coverage, and more than 4
helices. This resulted in a set of 25 membrane proteins with up
to 487 residues (up to 14 transmembrane helices) in 23 structur-
ally diverse families. This set includes the human b2 adrenergic
receptor (GPCR family), the S. typhimurium arginine/agmatine
antiporter ADIC (amino acid/polyamine transporter superfamily),
and the E. coli glycerol-3-phosphate transporter (GlpT; major
facilitator superfamily) (Table 1 and Data S3–S5).
The EVfold_membrane protocol provides a ranked set of pre-
dicted structures for each protein, which we then compare to
a cognate crystal structure. The combined score used for
ranking the generated models reliably identifies structures of
high accuracy and, in some cases, even the best model in
the top ten (Tables 1 and S1 and Figure S4). Overall, 21 of our
test set of 23 diverse a-helical transmembrane proteins are
reliably predicted, with template modeling (TM) scores of 0.5–
0.7 and Ca-rmsd 2.6–4.8 A˚ over > 70% of the length (Figures
3A and 3B and Tables 1 and S1). Template modeling score
(range 0.0–1.0) is considered reasonable when >0.5 and is
comparable across proteins of varying lengths (Zhang and Skol-
nick, 2004). This blindly predicted set allows assessment of
the relationship between the number of evolutionary constraints
that are not spatially close in the cognate crystal structure (false
positives) and the accuracy of our 3D structure prediction (Fig-
ure S5). The highest-ranked evolutionary constraints (1–20)
contain2% false positives, and the proportion of true positives
decreases monotonically as a function of the number of
constraints (Figure S3). However, the accuracy of folding, as
measured by TM score, is remarkably robust to variation in the
proportion of true positives and is stable over many different
folding experiments in which the number of constraints is
steadily increased (Figure 3C). Details of the distribution of pre-
dicted contacts along the protein chain and the precise nature
of false positives, such as mutual effective cancellation, may
contribute to this robustness.
Currently, state-of-the-art approaches for de novo folding are
based primarily on searching for sequence-similar fragments in
3D structure databases followed by fragment assembly using
specially designed empirical force fields. The key limitation is
the enormous size of the conformational search space. Our
approach overcomes this limitation by using the information
in the evolutionary constraints and its direct translation to 3D
coordinates via distance geometry, leading to a considerable
performance advantage relative to earlier methods. The advan-
tage is apparent in terms of (1) protein size range, (2) prediction
accuracy, (3) efficiency of conformational search, and (4) lack of
dependence on fragments and helix-helix contacts from previ-
ously solved 3D structures. More than 50% of membrane
proteins have 8–14 transmembrane helices. Here, we report
models of proteins with up to 14 helices and anticipate that our
Figure 3. Accuracy of Blinded 3D Structure Prediction for Candidates with Known Structure
(A) Structural superpositions of predicted structures (blue) onto experimental structures (gray). First panel for each protein: side view from within the membrane;
second panel: top-down view from noncytoplasmic side. All figures were rendered with PyMOL.
(B) Accuracy of 3D structure prediction for candidates with known structure. Template modeling score (TM score) (Zhang and Skolnick, 2004) of the best model
for each protein plotted against the number of sequences in the multiple sequence alignment, normalized by modeled protein length.
(C) 3D prediction accuracy is surprisingly stable as the true positive rate of evolutionary constraints decreases, going down the list of ranked ECs. The TM score of
the best prediction (blue) and the true positive rate (red) are plotted for increasing numbers of evolutionary constraints (divided by the number of residues in the
protein to allow comparison between proteins). Distance cut-offs to define true contacts of true positive rate are 5 A˚ (red dots), 7 A˚ (red dashes), and 8A˚ (red).
See also Figures S3 and S4 and Data S2–S5.method will allow the prediction of even larger membrane
proteins, as we see no deterioration of accuracy with size (up
to almost 500 residues) and obtain accurate 3D fold with as little
as one constraint per residue over the entire size range. In
contrast, previous prediction tools have been used to generate
models for proteins with only four to seven helices reported
(Barth et al., 2009). To compare accuracy, we predicted struc-
tures for five of the same proteins predicted by Barth et al.
(2009) (Table S2). Our method reached the threshold coordinateaccuracy of 4 A˚ over comparable or significant larger regions
(e.g., 89% rather than 40% of residues for bovine rhodopsin),
and it explored conformational search space more efficiently
(e.g., 500 candidate models compared to 200,000 generated
in Barth et al. [2009]). As a result of this efficiency gain, in current
practice, EVfold all-atommodels can be generated on a laptop in
a few minutes per structure, without the need for supercom-
puters. A possible conceptual and practical advantage of the
EVfold_membrane method is information about the roles ofCell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc. 1613
residues and residue interactions in protein function as a result of
extracting coupling information at the protein level filtered
through functional selection over a myriad of evolutionary
experiments.
Although the results from our validation set of proteins are
encouraging, they raise the question of whether we can predict
the success of our approach for any given protein of interest,
based on sequence information alone. In general, the accuracy
of the predicted model increases with the number of sequences
in the alignment normalized for the length of the protein (Fig-
ure 3B). For instance, the predicted structures of two proteins,
a proton/peptide symporter and a bile acid symporter, have
the lowest TM scores (0.4–0.5) compared to their cognate crystal
structures and have among the lowest number of sequences per
residue in their input alignments (26 and 3, Table S1).
Conversely, the predicted structure of bovine rhodopsin has
131 sequences per residue and an excellent TM score of 0.7.
Thus, the number of sequences, the diversity of sequences,
and the coverage of the length of the protein will no doubt be
important metrics in estimating the likely accuracy of predictions
and will be used to develop metrics for more accurate and more
subfamily-specific structure calculations.
Evolutionary Constraints Include Homo-Oligomer
Contacts
Not all residue interactions that are strongly constrained by
evolution are close in the 3D structure of the monomeric protein.
Residue pairs close in transmembrane protein homo-oligomers
may thus appear in conflict with other monomer constraints
and/or the predicted 3D fold.
For example, in the computed structure of the ABC transporter
S. typhimurium MsbA, evolutionary couplings between trans-
membrane helix 2 and transmembrane helices 5 and 6 are
false positives with respect to monomer structure but true
positives with respect to the crystal structure dimer interface
(PDB: 3b60; Ward et al., 2007) (Figure 4A). Similarly, E. coli
MetI has a cluster of evolutionary couplings with residues that
are not in contact in the monomer but form contacts in the dimer
(PDB: 3dhw; Kadaba et al., 2008). If successfully identified,
the removal of the conflicting oligomer evolutionary couplings
from the folding calculation improves the accuracy of predic-
tion for the monomer (test done in MsbA and MetI; data not
shown).
We also predict oligomer contacts for proteins of unknown 3D
structures, such as AdipoR1. To identify potential dimerization
contacts, we noted that some evolutionary constraints are
inconsistent with the monomer predicted structure and may
therefore be involved in the putative dimerization interface. Inter-
preting these evolutionary constraints as distance constraints
between residues in two separate monomer structures shows
that the AdipoR1 dimer interface involves contacts between
the loop from helices 4 to 5 and both helices 1 and 7 (Figure 4B).
Consistent with our prediction of the dimerization region are
experimental observations that mutations in the GXXXG motif
on transmembrane helix 5 of AdipoR1 disrupt dimerization (Ko-
sel et al., 2010). Q335 on the transmembrane helix 7 is unusually
strongly constrained, in spite of a low 19% conservation level as
a single residue, as a partner in more than 11 evolutionary1614 Cell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc.couplings, some of which may be across this putative interface
(Figure 4B). These examples suggest that homo-oligomer
contact detection using evolutionary coupling pairs may yield
valuable testable information. It remains an algorithmic chal-
lenge to identify such evolutionary couplings between the
components of oligomers in a more automated fashion.
Evolutionary Constraints Reflect Conformational
Change
Many proteins can adopt different distinct conformations as part
of their function (Tokuriki and Tawfik, 2009). Can we correctly
predict more than one 3D conformation of a protein by extracting
and analyzing evolutionary couplings from one set of protein
sequences? We investigated this challenge by an analysis of
known structures and genuine prediction. GlpT and OCTN1
belong to the functionally diverse subfamilies of the large major
facilitator superfamily, secondary membrane transporters that
move substrate across the membrane by alternating between
two alternative conformations of the channel—one open to the
cytoplasm and the other open to the periplasm or extracellular
space (Boudker and Verdon, 2010; Huang et al., 2003).
Comparing the predicted model of Glpt to the crystal structure
1pw4 (cytoplasm-open conformation), we noticed that the pre-
dicted cytoplasmic side of the transporter channel is not as
open as in the crystal structure (Figure 3A). The Glpt evolutionary
couplings differ from contacts made in the GlpT crystal structure
in an apparently false positive set that would, however, be in
contact in the suspected alternative cytoplasm-closed confor-
mation (Figure 5A). Similarly, a set of contacts can be identified
that are consistent only with the cytoplasm-open conformation
(selection rules in Supplemental Information). To test whether
the two alternative sets of evolutionary couplings for GlpT protein
would be sufficient to predict the two different conformations,
we refolded GlpT with both sets separately (Figure 5A and
Table S3). As expected, when we exclude evolutionary coupling
pairs between the domains on the periplasmic side, we obtain
models in a closed-to-cytoplasm conformation, similar in overall
structure to the known closed conformation structure of the
L-fucose-proton symporter FucP (PDB: 3o7q) and to a homology
model of LacY (Radestock and Forrest, 2011) but distinct
from the known open GlpT structure of GlpT (PDB: 1pw4). The
arrangements of transmembrane helices 5 and 8 and transmem-
brane helices 2 and 11 in the two folded models differ as ex-
pected for ‘‘rocking’’ changes between alternative transporter
conformations (Lemieux et al., 2004). Therefore, plausibly, the
evolutionary constraints in the sequence family of GlpT, when
decomposed into two overlapping sets, reflect two alternative
conformations of the channel.
As human OCTN1 (unknown structure) is also from the major
facilitator superfamily, we wondered whether evolutionary
couplings in OCTN1 also contained information about alternative
conformations. We compared our top-ranked model of OCTN1
to all structures in the PDB and found significant hits to known
structures in the major facilitator superfamily, including those
of GlpT and FucP. The predicted OCTN1 models, as above
for GlpT, looked like an intermediate conformation between
outward-open and inward-open, consistent with the expectation
that both states are constrained by evolution (Figure 1 and
Figure 4. Evolutionary Constraints on Residue Pairs in Oligomerization Interfaces
Contact maps of top-ranked predicted ECs (red stars in A and B) overlaid on crystal structure contacts (gray, known only in A). Residue pairs coevolving due to
intermonomer contacts in the homo-oligomer (black circles) in an overlay of top-ranked predicted evolutionary constraints (red) experimental structure contacts
(gray), where known, on contact maps for each protein. In the monomer (blue or green ribbon with blue or green residue balls), the corresponding residue pairs
would be false positive contacts (blue with blue or green with green do not make contact in the monomer) but would be true positives in the homo-oligomer
structure (contacting blue-green pairs).
(A) Four examples of inference of oligomer contacts from ECs of known 3D structures.
(B) Predicted dimer contacts of AdipoR1, shown on predictedmonomer structures. EC pairs (black circles) at a large distance inmonomer structure (23 A˚, green
with green, blue with blue) are close (green-blue contact pair) in predicted dimers. Predicted dimer cartoon (right) is a rough estimate, produced bymanual-visual
docking of monomers, satisfying the majority of predicted dimer interface EC pairs (middle).
See also Figure S5.Data S2). Examination of the distribution of EC pairs suggests
that they contain information for two conformations of the
transporter (Figure 5C).Given that our evolutionary constraints contain information
about the different states of members of the major facilitator
superfamily, we anticipate that evolutionary constraints mightCell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc. 1615
Figure 5. Coevolved Pairs Consistent with Open and Closed Conformations of Proteins in the Major Facilitator Family
(A) (Center) Contact map for E. coli GlpT, residues less than 5 A˚ apart in the crystal structure (gray, PDB: 1pw4) overlaid with the top 350 ECs (red stars). The
similarity of the upper-left and lower-right quadrants reflect the similarity of the structure and sequences of the two domains. Upper-right and lower-left quadrants
show the predicted interdomain contacts (all stars). Stripes in lower-left and upper-right quadrants cover interdomain contacts involving the periplasmic end of
the helices/loops (green strips, lower-left) and the cytoplasmic ends of the helices/loops (blue strips, upper-right). Predicted ECs located where stripes of the
same color cross each are likely interdomain contacts (green and blue stars) (Table S3). (Right and left) Refolded GlpT from extended polypeptide excluding blue
constraints for cytoplasmic side open (right) and excluding green constraints for cytoplasmic side closed (left). The schematics (right and left top) indicate
contacts used (arrows) and not used (scissors) in refolding to get the two alternative conformations. Open conformation (right) is similar to crystal structure
(Table 1) and is reproduced via refolding; closed conformation structure (left) is previously unknown and predicted here via refolding.
(B) Details from the models in (A). The two pairs of helices (H5/8 and H2/11) in the predicted models of GlpT are thought to change conformation dependent on
state of substrate binding (closed at cytoplasm, green ribbons, left; open at cytoplasm, blue ribbons, right). Differences in interhelical angles are driven by the
alternative use of top (green) or bottom (blue) contact pairs derived from ECs in refolding (Table S3).
(C) Predicted EC pairs of human OCTN1 (red stars on contact map) determine the overall fold. Stripes in lower-left and upper-right quadrants cover the predicted
periplasmic end of the helices/loops (green) and the cytoplasmic ends of the helices/loops (blue). Predicted evolutionary constraints (not differentiated by star
color) located where stripes of the same color cross each other are predicted interdomain contacts. 3D structures of alternative conformations of OCTN1 are not
shown here. For predicted OCTN1 structure details, see Figure 1, Table 1, and Data S2.
See also Table S3.
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Figure 6. Known Functional Sites Contain Residues Strongly Involved in Evolutionary Constraints
(A andB) The total evolutionary coupling score on individual residues reflects likely functional involvement (top 5%, red spheres; top 6%–15%, orange spheres; all
others, yellow ribbon); scores are as in Table S4.
(A) The ligands carazolol in Adrb2 and retinal in Opsd (blue spheres) were positioned in the predicted structure by globally superimposing the most accurate
predicted model and the experimental structure plus ligand (experimental structures are not shown; no docking was performed).
(B) Residues with high evolutionary coupling scores mapped on the predicted structures of unknown structure transmembrane proteins.
(C and D) Above average accuracy of blinded prediction of atomic positions of the binding site of Adrb2 (1.6 A˚ Ca-rmsd over 9 residues, C) and bovine rhodopsin
(1.8 A˚ Ca-rmsd over 10 residues, D).
(E) Likely functional residues (high evolutionary coupling scores) in AdipoR1 on the predicted cytoplasmic side (known functional residues in magenta, predicted
functional residues in red).
See also Table S4.help to unravel the precise conformational changes upon
substrate binding and transport.
Evolutionary Constraints Mark Functional Residues
Conservation of amino acids in proteins in single columns is
routinely used to infer functional importance of the site and
assess the consequences of genetic variation. As our evolu-
tionary analysis reflects both residue-residue correlations and
single residue terms, we wondered whether the strength of
evolutionary couplings on a residue is an indication of its general
functional importance for the protein. To assess this, we calcu-
late the total evolutionary coupling score for a given residue bysumming the evolutionary coupling values over all high-ranking
pairs involving that residue (Experimental Procedures, Table
S4, Data S6). We find that, in Adrb2, Opsd, and GlpT, residues
with high total coupling scores line the substrate-binding
sites and affect signaling or transport; for instance, W109,
D113, and Y141 in Adrb2; K296, W265, and H211 in Opsd;
and Y393, H165, and K90 in GlpT (Huang et al., 2003; Law
et al., 2008; Valiquette et al., 1995) (Figure 6A). Higher prediction
accuracy of atomic coordinates near the active sites for Adbr2
and Opsd than for the average of the protein reflects the multiple
constraints, i.e., high total coupling score, on these sites
(Figure 6C).Cell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc. 1617
In the unknown structure AdipoR1, residues with a high total
coupling score include putative enzymatic residues S187,
H191, D208, H337, and H341 (Holland et al., 2011; Pei et al.,
2011) together with the top three high-scoring residues, C195,
A235, and Q335, which cluster together (within 4 A˚) in the pre-
dicted 3D structure, indicating that they are important in the
activity of AdipoR1 (Figure 6B). Similarly, clusters of residues
with high scoring in OCTN1 make potential salt bridges at the
cytoplasmic side of the domains (169R-220E, 397R-450E),
cluster in the central transport pore (N210, Y211, C236, E381,
and R469), and are potentially involved in conformational
changes. Residues with high total coupling scores in our pre-
dicted models of human MT-ND1 are clustered in a periplas-
mic-oriented pocket and along the mitochondrial interface with
the hydrophilic domain and the putative quinine-binding site
(Figure 6B) (Efremov and Sazanov, 2011). Mutations in MT-
ND1 at residues Y30 and M31 are associated with Alzheimer’s
disease and Leber’s hereditary optic neuropathy (LHON) (Johns
et al., 1992), and these two residues have particularly high total
coupling scores, suggesting that they are functionally con-
strained by interactions with several other residues.
We hypothesize that many evolutionary coupling pairs,
whether or not close in the 3D structure, may be functionally
important. The examples presented here, however, are not the
result of an exhaustive analysis. Therefore, reliable functional
interpretation of evolutionary constraints, whether indicative of
intramonomer contacts or not, remains a challenge. Our results
here provide some confidence in the validity of the conceptual
link between the strength of evolutionary constraints on a residue
and its functional importance, whether through location in
binding sites or involvement in conformational changes.
DISCUSSION
The process of evolution and the massive sequencing of
diverse species have provided the opportunity to compute
an important aspect of molecular phenotype, protein 3D
structure, and the EVfold method appears to achieve a useful
level of accuracy. However, a serious gap remains between
predicted and experimental structures. Though an overall
Ca-rmsd of 4–5 A˚ across hundreds of residues does imply
the correct identification of the overall fold, it also implies
that particular atomic positions, the interdigitation of packed
side chains and loop conformations can be incorrect in detail,
although they appear more accurate near heavily constrained
binding sites. To improve the quality of the predicted contacts
and resulting atomic structures, four areas of focus hold
particular promise: (1) improved information handling in
sequence space, such as improvements in weighting schemes
for sequences, evaluation of alignment diversity, inclusion of
higher-order terms, and consistency filters to reduce the
number of false positive pairs; (2) automated procedures to
distinguish between internal and homo-oligomer pair contacts
and to identify contacts reflecting alternative conformations; (3)
the use of fragments imported from known structures; and (4)
the use of advanced energy refinement methods, including
molecular dynamics and Monte Carlo simulations (Dror et al.,
2011; MacCallum et al., 2011).1618 Cell 149, 1607–1621, June 22, 2012 ª2012 Elsevier Inc.Even at the current level of accuracy, a number of applications
may have immediate benefit. One is the development of hybrid
methods of structure determinations. In NMR spectroscopy,
inclusion of evolutionary constraints from sequences may permit
structure determination with a smaller number of chemical shifts
and NOEs, saving machine time or permitting the solution of
larger protein structures than previously reachable. In protein
crystallography, the solution of a 3D structure from a native
data set alone may become possible, without the need for heavy
atom derivatives or MAD phasing, via molecular replacement
searches starting with predicted 3D structures. If successful in
future work, such methods would significantly increase the
productivity of structural biology and the rate of solving new
structures.
Beyond structure determination, the predictedmodels may be
useful for pharmacological selection of compounds via docking
calculations. The observation of exceptionally strong evolu-
tionary constraints near active sites, as reported here for a few
proteins, is a favorable starting point, as the accuracy of protein
coordinates in active sites and binding sites is an important
requirement for computational drug screening. In molecular
biology in general, the placement of constrained pairs in the
context of known or predicted 3D structures may also provide
useful information to guide functional mutational experiments.
Similarly, evolutionarily coupled pairs may be excellent design
elements for engineering new proteins in synthetic biology
(Russ et al., 2005) and may have a strategic role in the protein
folding process (Fersht, 2008).
Inferred evolutionary constraints may also help guide the
computational assembly of protein monomers into complexes,
with or without low-resolution information from electron diffrac-
tion or similar methods. The computational extension to
predict the structure of protein complexes is a straightforward
generalization using pairwise sequence alignments, with a
homologous pair of sequences in place of a single sequence
and derivation of evolutionary couplings not within a protein
but between two potentially interacting proteins (Pazos and
Valencia, 2002; Skerker et al., 2008; Weigt et al., 2009). We
see no practical limit in the size of complexes accessible to
such computation, provided sufficiently diverse sequence
information is available, as the configuration of even large com-
plexes with tens of constituents effectively can be deduced
from calculation of all pairwise protein interactions in the com-
plex. The nuclear pore complex, as solved by computational
assembly from protein-protein pair information determined
experimentally, would be an excellent test case (Fernandez-
Martinez et al., 2012).
Looking forward, how much information about 3D folds of
transmembrane proteins can be gained if this kind of method
is broadly and successfully applied? A current snapshot of
protein families, as organized in the PFAM 26.0 database, has
about 2million transmembrane proteins in 1,259 protein families,
of which 107 families have one or more 3D structures. An addi-
tional 150 families appear to have sufficient sequences to be
modeled using evolutionary couplings, including those with
b sheet folds (not tested here). Given the current efficiency and
rapid development of DNA sequencing technology, perhaps
another 500 families would accrue similar levels of sequence
information to have their folds determined in about 2 years, with
subsequent rapid growth likely.
On a practical level, the simplicity of the theoretical approach
and efficiency of the computational implementation, with
computation in a couple of hours for proteins up to 500 residues,
will allow availability of the EVfold procedure to a broad commu-
nity of researchers, not limited to structural biologists, in either
precomputed or server mode. For the proteins described here,
detailed data, such as 3D coordinates and evolutionary
constraints, as well as software code for their calculation, are
available at http://evfold.org/transmembrane. Computational
protein folding using evolutionary constraints may thus drive
new experimental approaches that will harness the massive
explosion in genomic sequencing by reading the evolutionary
footprints of protein structure and function.
EXPERIMENTAL PROCEDURES
Full methods are described in the Extended Experimental Procedures. All EC
scores and residue name mappings are in Data S1, and all 3D model coordi-
nates, input files, and analysis are in Data S2–S5 and online at http://evfold.
org/transmembrane.
Selection of Membrane Proteins
To test our ability to predict the 3D structure of a-helical multipass membrane
proteins (R5 helices), we compiled a set of 25 proteins from 23 different Pfam
families from the database of membrane proteins of known 3D structure
(http://blanco.biomol.uci.edu/mpstruc/listAll/list). We optimized the set for
nonredundancy and depth of sequence alignment. The set of interesting
membrane protein families with no known representative structure was
chosen by selecting transmembrane proteins that are drug targets, using the
DrugBank (Knox et al., 2011), Pfam (Punta et al., 2012), and CAMPS (Neumann
et al., 2012) databases. For this initial study, we selected proteins with at least
23 L sequences in the family alignment (L = protein length) and with more than
70% coverage (breadth).
Multiple Sequence Alignments
Multiple sequence alignments for each candidate protein were obtained using
HHblits (Remmert et al., 2012) sequence searches against the UniProt
database at a range of different E values. The alignment used for constraint
inference was selected by choosing the E value giving the best trade-off
between a maximum number of sequences in the alignment and sufficient
coverage of the entire transmembrane domain bymost sequences in the align-
ment (all alignments are available at http://www.evfold.org/transmembrane)
(Figure 2A and Figure S2).
Inference of Evolutionary Constraints from Sequence Variation
To predict the 3D structure of membrane proteins, we devised a membrane
protein-specific version of the original EVfold method (Marks et al., 2011)
and named it EVfold_membrane. First, a set of evolutionary couplings between
residue pairs is inferred by computing the parameters in a global maximum
entropy probability model of the multiple sequence alignment (Data S1). This
set is ranked according to coupling strength and filtered for inconsistency
with predicted membrane topology and predicted secondary structure.
Ab Initio Folding from Membrane Protein Sequence
All predictions started from fully extended polypeptide using increasing
numbers of evolutionary constraints, from 40 to L constraints (L = length of
modeled sequence) in steps of 10, with 20 models generated for each EC
bin. Additionally, we added distance and dihedral angle constraints consistent
with predicted secondary structure. The folding protocol uses default
modules from the CNS software suite (Brunger, 2007), which consists of
distance geometry, simulated annealing, and energy minimization stages.Each model takes about 1–2 min of computing time on a single CPU for
a protein of average size.
Clustering and Ranking of Predicted Models
Although only a small number of models are generated, we devised a ranking
scheme based on simple intuitive requirements for membrane proteins, such
as satisfaction of unused constraints (adapted from Miller and Eisenberg,
2008), predicted secondary structure, and predicted lipid exposure agreement
in the folded models. Structures are additionally clustered using MaxCluster
(Siew et al., 2000) single-linkage clustering to eliminate high-ranked outliers
belonging to small clusters.
Assessment of Evolutionary Constraints and Prediction Quality
Predicted evolutionary constraints were compared to observed contacts from
crystal structures using contact maps and false positive rate plots (Data S2–S5
and http://evfold.org/transmembrane). Predicted models of known structures
were compared to a representative crystal structure (Table S1) using the
Ca-rmsd and TM and GDT scores calculated with MaxCluster (Zemla, 2003;
Zhang and Skolnick, 2005). Predicted 3D structures for transmembrane
proteins of unknown structure, for which no family member structure has
been solved yet, are compared for structural homology against a representa-
tive set of proteins in the Protein Data Bank (PDB) using structural alignments
with DALI (Holm and Sander, 1993) and FATCAT (Ye and Godzik, 2004).
Residues with High Total Evolutionary Coupling Scores
To quantify the strength of evolutionary constraints on a residue, we calculated
the total strength of evolutionary constraints per residue. For each residue,
we sum the pair scores obtained from the maximum entropy model over all
high-ranking pairs that it is involved in, down to a predefined cutoff (Data S1).
The score for each residue is normalized by the average score for all residues
in the full sequence (Table S4).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, four tables, and six data files and can be found with this article online
at doi:10.1016/j.cell.2012.04.012.
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